Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD-486019 with twelve mammalian isoforms: kinetic and X-Ray crystallographic studies

2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate

Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies

Carbonic anhydrase II, Carbonate dehydratase II, CA-II, Carbonic anhydrase C, CAC

MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLK
GGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVV
DVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELM
VDNWRPAQPLKNRQIKASFK

50mM Tris-HCl pH 7.7-7.8, 2mM sodium 4-(hydroxymercury)benzoate, VAPOR DIFFUSION, HANGING DROP, temperature 277K

Human carbonic anhydrase II complexed with 667-coumate

Chemically synthesized. This sequence occurs naturally in humans(homo sapiens).

THE LIGAND 2C7 IS NEW ANTITUMOR SULFAMATE AND CAN BE ALSO CALLED AS EMD486019.
THE NUMBER 126 IS SIMPLY SKIPPED IN THE NUMBERING. THE GAP IS IN THE SEQUENCE NUMBERING OF MODEL 1CA2, THAT IS THE STARTING MODEL FOR ALL CA2 STRUCTURES.

HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS

carbonic anhydrase, inhibitors, antiglaucoma, OAO-ACID, Acetylation, Cytoplasm, Disease mutation, Lyase, Metal-binding, Polymorphism, Zinc